The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches. Issue 2 (19th January 2021)

• Record Type: Journal Article
• Authors: Macaluso, Fabio Salvatore; Fries, Walter; Viola, Anna; Centritto, Andrea; Cappello, Maria; Giuffrida, Enrica; Privitera, Antonino Carlo; Piccillo, Giovita; Magnano, Antonio; Vinci, Elisa; Vassallo, Roberto; Trovatello, Antonino; Belluardo, Nunzio; Giangreco, Emiliano; Camilleri, Salvatore; Garufi, Serena; Bertolami, Carmelo; Ventimiglia, Marco; Renna, Sara; Orlando, Rosalba; Rizzuto, Giulia; Orlando, Ambrogio
• Is Part Of: Inflammatory bowel diseases. Volume 27:Issue 2(2021)
• Publication Date: 2021-01-19
• Subjects: biosimilar infliximab -- safety -- SB2 -- switch; Inflammatory bowel diseases -- Periodicals; Colitis, Ulcerative -- Periodicals; Crohn Disease -- Periodicals; Inflammatory Bowel Diseases -- Periodicals; 616.344
• DOI: 10.1093/ibd/izaa036
• Languages: English
• ISSNs: 1078-0998